Register entry

TOLMAR Inc.

Data as of · How to read this entry

Registered sites
2
Active NDC listings
14
Live patents
45
Countries
1
Base
United States
Authorisation

Registered operations

Analytical testing2Labelling2Finished drug manufacture2Packaging2
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
TOLMAR, INC.Registrant: TOLMAR Inc.2409 Research Blvd, Fort Collins, Colorado (CO) 80526, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging3006218434015554360
TOLMAR, INC.Registrant: TOLMAR Inc.9351 Eastman Park Drive, Windsor, Colorado (CO) 80550, United States (USA)Analytical testing, Labelling, Finished drug manufacture, Packaging3010755927079806054
Catalogue

Drug listings by form and route

14

14 active NDC listings: 14 human prescription drug. By marketing category: NDA 13, ANDA 1.

Dosage formNDCs
injection, suspension, extended release5
kit5
capsule, liquid filled3
shampoo, suspension1
RouteNDCs
subcutaneous9
oral3
topical1
Labeller name on the listingNDCs
tolmar inc.14
Exclusivity

Patents and exclusivities

45
PatentProductCoversExpiry
11331325JATENZOtestosterone undecanoateuseJan 2027
8241664JATENZOtestosterone undecanoateproductMar 2029
10543219JATENZOtestosterone undecanoateuseApr 2030
10617696JATENZOtestosterone undecanoatesubstance, productApr 2030
11179403JATENZOtestosterone undecanoateuseApr 2030
11426416JATENZOtestosterone undecanoateuseApr 2030
8778916JATENZOtestosterone undecanoateproductApr 2030
8492369JATENZOtestosterone undecanoateproductDec 2030
11564933JATENZOtestosterone undecanoateuseApr 2039
12605391JATENZOtestosterone undecanoateuseApr 2039
11771841ELIGARD KIT, FENSOLVI KITleuprolide acetatesubstance, productDec 2041
11931559ELIGARD KIT, FENSOLVI KITleuprolide acetatesubstanceDec 2041
12397120ELIGARD KIT, FENSOLVI KITleuprolide acetateuseDec 2041
Catalogue

Marketed products

14
BrandGeneric nameForm / routeNDC
ELIGARDLeuprolide Acetatekit, subcutaneous62935-223NDA
ELIGARDLeuprolide Acetatekit, subcutaneous62935-303NDA
ELIGARDLeuprolide Acetatekit, subcutaneous62935-453NDA
ELIGARDLeuprolide Acetatekit, subcutaneous62935-753NDA
EligardLeuprolide acetateinjection, suspension, extended release, subcutaneous62935-227NDA
EligardLeuprolide acetateinjection, suspension, extended release, subcutaneous62935-306NDA
EligardLeuprolide acetateinjection, suspension, extended release, subcutaneous62935-461NDA
EligardLeuprolide acetateinjection, suspension, extended release, subcutaneous62935-756NDA
FensolviLeuprolide Acetatekit62935-153NDA
FensolviLeuprolide Acetateinjection, suspension, extended release, subcutaneous62935-163NDA
Jatenzotestosterone undecanoatecapsule, liquid filled, oral69087-158NDA
Jatenzotestosterone undecanoatecapsule, liquid filled, oral69087-198NDA
Jatenzotestosterone undecanoatecapsule, liquid filled, oral69087-237NDA
KetoconazoleKetoconazoleshampoo, suspension, topical63646-010ANDA
Neighbours

Registered in the same town

1
Compare

Comparable companies in United States

Enquiry

Common questions

Is TOLMAR Inc. FDA approved?
TOLMAR Inc. holds 2 FDA-registered establishments in the United States. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are TOLMAR Inc.'s drugs manufactured?
The FDA register lists Fort Collins, CO; Windsor, CO. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does TOLMAR Inc. make?
14 products are listed under TOLMAR Inc. in the openFDA NDC Directory, most often as injection, suspension, extended release; kit; capsule, liquid filled. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.